Check out the business making headings after the bell on Tuesday: Atlassian– Shares of the Australian software application business ticked up 1% on revised revenue guidance for the fiscal third quarter. Atlassian now expects revenue between $566 million and $572 million. Analysts polled by FactSet formerly predicted earnings of $487.2 million for the businesss third quarter. The brand-new projection is also above Atlassians previous earnings guidance for the quarter. Stitch Fix– Shares of the individual styling service moved 3.2% after the company revealed that founder and CEO Katrina Lake will end up being the executive chairperson and Elizabeth Spaulding will take over as CEO, reliable Aug. 1. Endo International– The pharmaceutical companys shares ticked up slightly after the business revealed that appealing stage 3 information on a cellulite treatment was released in the main journal of the American Society of Dermatologic Surgery. The information showed that the treatment offers a medically significant improvement in the look of moderate to extreme cellulite in the butts of adult women compared to placebo. Amicus Therapeutics– The biopharmaceuticals businesss shares increased 3% after experts at Cantor Fitzgerald updated the stock to obese from neutral, pointing out the companys appealing gene treatment results.Discovery– Discoverys Class A and Class C shares dropped 3.8% and 5.1%, respectively, after CNBCs David Faber reported that Credit Suisse continues to unload positions in the media business as a result of the blow up of Archegos Capital Management. Citing traders, Credit Suisse sold 19 countless the media companys Class A shares and 22 million in Class C stock.

By